Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.
Enfield KSS, Colliver E, Lee CSY, Magness A, Moore DA, Sivakumar M, Grigoriadis K, Pich O, Karasaki T, Hobson PS, Levi D, Veeriah S, Puttick C, Nye EL, Green M, Dijkstra KK, Shimato M, Akarca AU, Marafioti T, Salgado R, Hackshaw A, Consortium T, Jamal-Hanjani M, van Maldegem F, McGranahan N, Glass B, Pulaski H, Walk E, Reading JL, Quezada SA, Hiley CT, Downward J, Sahai E, Swanton C, Angelova M. Enfield KSS, et al. Among authors: glass b. Cancer Discov. 2024 Apr 6. doi: 10.1158/2159-8290.CD-23-1380. Online ahead of print. Cancer Discov. 2024. PMID: 38581685
Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments.
Rüschoff J, Kumar G, Badve S, Jasani B, Krause E, Rioux-Leclercq N, Rojo F, Martini M, Cheng L, Tretiakova M, Mitchell C, Anders RA, Robert ME, Fahy D, Pyle M, Le Q, Yu L, Glass B, Baxi V, Babadjanova Z, Pratt J, Brutus S, Karasarides M, Hartmann A. Rüschoff J, et al. Among authors: glass b. Virchows Arch. 2024 Apr;484(4):597-608. doi: 10.1007/s00428-024-03795-8. Epub 2024 Apr 4. Virchows Arch. 2024. PMID: 38570364
Plain language summary of the TRANSFORM study primary analysis results: lisocabtagene maraleucel as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen.
Abramson JS, Solomon SR, Arnason J, Johnston PB, Glass B, Bachanova V, Ibrahimi S, Mielke S, Mutsaers P, Hernandez-Ilizaliturri F, Izutsu K, Morschhauser F, Lunning M, Crotta A, Montheard S, Previtali A, Ogasawara K, Kamdar M. Abramson JS, et al. Among authors: glass b. Future Oncol. 2024 Mar 28. doi: 10.2217/fon-2023-0898. Online ahead of print. Future Oncol. 2024. PMID: 38547003 Free article. Review.
Planetary Protection Knowledge Gap Closure Enabling Crewed Missions to Mars.
Spry JA, Siegel B, Bakermans C, Beaty DW, Bell MS, Benardini JN, Bonaccorsi R, Castro-Wallace SL, Coil DA, Coustenis A, Doran PT, Fenton L, Fidler DP, Glass B, Hoffman SJ, Karouia F, Levine JS, Lupisella ML, Martin-Torres J, Mogul R, Olsson-Francis K, Ortega-Ugalde S, Patel MR, Pearce DA, Race MS, Regberg AB, Rettberg P, Rummel JD, Sato KY, Schuerger AC, Sefton-Nash E, Sharkey M, Singh NK, Sinibaldi S, Stabekis P, Stoker CR, Venkateswaran KJ, Zimmerman RR, Zorzano-Mier MP. Spry JA, et al. Among authors: glass b. Astrobiology. 2024 Mar;24(3):230-274. doi: 10.1089/ast.2023.0092. Astrobiology. 2024. PMID: 38507695
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT.
Passweg JR, Baldomero H, Ciceri F, de la Cámara R, Glass B, Greco R, Hazenberg MD, Kalwak K, McLornan DP, Neven B, Perić Z, Risitano AM, Ruggeri A, Snowden JA, Sureda A. Passweg JR, et al. Among authors: glass b. Bone Marrow Transplant. 2024 Mar 4. doi: 10.1038/s41409-024-02248-9. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38438647 Free article.
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.
Salwender H, Weinhold N, Benner A, Miah K, Merz M, Haenel M, Jehn C, Mai E, Menis E, Blau I, Scheid C, Hose D, Seckinger A, Luntz S, Besemer B, Munder M, Brossart P, Glass B, Lindemann HW, Weisel K, Hanoun C, Schnitzler P, Klemm S, Goldschmidt H, Raab M, Elmaagacli A. Salwender H, et al. Among authors: glass b. Hematology. 2024 Dec;29(1):2320006. doi: 10.1080/16078454.2024.2320006. Epub 2024 Feb 26. Hematology. 2024. PMID: 38407192 Clinical Trial.
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor.
Paviglianiti A, Ngoya M, Peña M, Boumendil A, Gülbas Z, Ciceri F, Bonifazi F, Russo D, Fegueux N, Stolzel F, Bulabois CE, Socié G, Forcade E, Solano C, Finel H, Robinson S, Glass B, Montoto S. Paviglianiti A, et al. Among authors: glass b. Bone Marrow Transplant. 2024 May;59(5):597-603. doi: 10.1038/s41409-024-02225-2. Epub 2024 Feb 8. Bone Marrow Transplant. 2024. PMID: 38331980 Free PMC article.
593 results